Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the best value stocks to buy now. On February 19, Regeneron Pharmaceuticals announced that the FDA accepted its BLA for garetosmab for Priority ...

Researchers in China recently published a study in Science Translational Medicine describing a new antibody cocktail for protection against two common viruses. The proposed preventative treatment ...

Therapeutic antibodies packaged into microparticles could be delivered with a standard syringe, avoiding the need for lengthy and often uncomfortable infusions. Antibody treatments for cancer and ...

Monoclonal antibodies are a type of biologic medication that can treat moderate to severe inflammatory bowel disease (IBD) by targeting specific inflammatory processes in your body. Your doctor might ...

Constant exposure to diverse diseases is an occupational hazard for all healthcare workers, especially those who work with children. Scientists have now plumbed the immune systems of pediatricians to ...

[WASHINGTON] The Federal Reserve unveiled a new proposal that further targets how examiners scrutinise banks’ risk after US President Donald Trump moved to rein in what he sees as the closing of ...

Immunotherapy uses the power of your immune system to fight your cancer. There are several types of immunotherapies. They include antibody therapies and CAR T-cell therapy. Immunotherapies are among ...

Canada’s first disease-slowing Alzheimer’s treatment offers new hope for patients at the same time as it presents new strains on a health system already struggling to support a growing dementia ...

BOULDER , CO, UNITED STATES, February 24, 2026 /EINPresswire.com/ — Mosaic Biosciences, a protein discovery and engineering company enabling the development of next ...

(MENAFN- GlobeNewsWire - Nasdaq) – ARCALYST ® (rilonacept) Q4 2025 and full year 2025 net product revenue of $202.1 million and $677.6 million, respectively – – ARCALYST 2026 net product revenue ...

Rituximab vs placebo significantly improved the 49-week relapse-free rate in adults with frequently relapsing or steroid-dependent adult-onset nephrotic syndrome. Adverse events were more common in ...

Ultomiris is a brand-name biologic medication prescribed for certain rare autoimmune disorders. Dosing of Ultomiris is done via intravenous (IV) infusions administered by a healthcare professional.